Table 3.
Correlation between the Methylation Status (MI ≥ 0.25) and Clinical Parameters
| MI ≥ 0.25 | ||
|---|---|---|
| P (%) | N (%) | |
| Sex | ||
| Male | 55 (78.57) | 0 (0.00) |
| Female | 15 (21.43) | 0 (0.00) |
| p | < 0.0001 | |
| Age | ||
| ≤ 20 | 1 (1.43) | 0 (0.00) |
| From 21 to ≤ 40 | 10 (14.29) | 0 (0.00) |
| From 41 to ≤ 60 | 35 (50.00) | 0 (0.00) |
| From 61 to ≤ 80 | 24 (34.29) | 0 (0.00) |
| p | < 0.0001 | |
| Histopathology | ||
| Type 1 | 3 (4.29) | 0 (0.00) |
| Type 2 | 19 (27.14) | 0 (0.00) |
| Type 3 | 48 (68.57) | 0 (0.00) |
| p | < 0.0001 | |
| Stage | ||
| I | 0 (0.00) | 0 (0.00) |
| II | 27 (38.57) | 0 (0.00) |
| III | 10 (14.28) | 0 (0.00) |
| IV | 33 (47.14) | 0 (0.00) |
| p | 0.0022 | |